Novartis to Split Drug Business to focus on AntiCancer Drugs

Novartis is looking out for splitting the Drug Business in to two sections. Out of which one section will be looking after Anti-cancaer Drugs while other drugs will be focused by another division

The division shows the growing importance of Oncology section to company.

“Novartis expects this change to help drive our growth and innovation strategy, with an increased focus and improved execution,” the company said in a statement.

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo




For Pharma Jobs: Click here

For Online shopping offers : Click Here

Yogesh Chaudhari
He is working as Assistant Professor at HSNCB’s Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar
Facebooktwittergoogle_plusredditpinterestlinkedinmail
Yogesh Chaudhari

Yogesh Chaudhari

He is working as Assistant Professor at HSNCB's Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar

Leave a Reply

Your email address will not be published. Required fields are marked *